GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lukas Biomedical 6814.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

17.60

-1.68%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 179.5m

FY2017FY2025

Net income

−TWD 85.6m

FY2017FY2025

Free cash flow

−TWD 69.9m

FY2017FY2025

Shareholders' equity

TWD 240.2m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueTWD 179.5mTWD 189.8mTWD 231.8mTWD 184.8mTWD 157.6mTWD 181.4mTWD 152.9mTWD 132.4mTWD 128.3m
Gross profitTWD 107.9mTWD 113.1mTWD 133.9mTWD 97.9mTWD 96.1mTWD 118.4mTWD 100.2mTWD 78.1mTWD 65.4m
Research and developmentTWD 82.8mTWD 94.7mTWD 77.3mTWD 55.9mTWD 55.0mTWD 35.4mTWD 29.2mTWD 22.8mTWD 17.8m
Operating income−TWD 81.1m−TWD 92.1m−TWD 43.6m−TWD 48.5m−TWD 43.1m−TWD 6.5m−TWD 7.0m−TWD 5.1m−TWD 2.5m
Net income−TWD 85.6m−TWD 94.4m−TWD 47.4m−TWD 50.1m−TWD 49.5m−TWD 10.5m−TWD 7.0m−TWD 20.0m−TWD 11.1m
Diluted earnings per share-2.05-2.25-1.28-1.36-1.50-0.32-0.20-1.01-2.34

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsTWD 426.8mTWD 476.5mTWD 441.2mTWD 479.7mTWD 531.2mTWD 523.6mTWD 556.1mTWD 469.4mTWD 480.1m
Cash and short-term investments—TWD 64.7mTWD 31.8mTWD 40.3mTWD 64.8mTWD 39.0mTWD 40.5mTWD 53.5mTWD 41.2m
Total liabilitiesTWD 186.6mTWD 150.7mTWD 161.1mTWD 152.2mTWD 244.6mTWD 232.7mTWD 254.7mTWD 161.2mTWD 307.8m
DebtTWD 46.7mTWD 115.2mTWD 125.9mTWD 112.4mTWD 221.5mTWD 212.3mTWD 230.1mTWD 128.9mTWD 140.3m
Shareholders' equityTWD 240.2mTWD 325.8mTWD 280.1mTWD 327.5mTWD 286.7mTWD 290.9mTWD 301.4mTWD 308.1mTWD 172.4m
Shares outstanding42m42m37m37m33m33m34m20m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−TWD 61.4m−TWD 70.5m−TWD 11.7m−TWD 7.4m−TWD 16.2mTWD 29.0mTWD 59.1mTWD 7.4m−TWD 5.3m
Capital spending−TWD 8.5m−TWD 6.8m−TWD 2.7m−TWD 3.0m−TWD 10.0m−TWD 9.0m−TWD 63.9m−TWD 12.2m−TWD 25.1m
Free cash flow−TWD 69.9m−TWD 77.3m−TWD 14.4m−TWD 10.4m−TWD 26.2mTWD 20.0m−TWD 4.8m−TWD 4.8m−TWD 30.4m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 87.9mTWD 92.4mTWD 97.4mTWD 117.6mTWD 114.3mTWD 48.8mTWD 136.0mTWD 78.8m
Gross profitTWD 51.7mTWD 48.6mTWD 58.3mTWD 68.6mTWD 65.3mTWD 26.6mTWD 71.3mTWD 48.0m
Operating income−TWD 41.1m−TWD 53.2m−TWD 38.9m−TWD 31.6m−TWD 11.9m−TWD 11.7m−TWD 35.4m−TWD 22.3m
Net income−TWD 42.5m−TWD 53.7m−TWD 40.7m−TWD 32.6m−TWD 14.7m−TWD 11.7m−TWD 38.4m−TWD 24.7m
Diluted earnings per share-1.02-1.28-0.97-0.89-0.40-0.32-1.04-0.75
Cash from operations−TWD 39.0m−TWD 38.0m−TWD 32.0m−TWD 8.0m−TWD 3.0m——−TWD 8.0m
Capital spending−TWD 8.0m−TWD 2.0m−TWD 2.0m—−TWD 1.0m——−TWD 5.0m
Free cash flow−TWD 47.0m−TWD 40.0m−TWD 34.0m—−TWD 4.0m——−TWD 13.0m
Total assetsTWD 452.5mTWD 476.5mTWD 579.5mTWD 441.2mTWD 466.4mTWD 479.7m—TWD 531.2m
Cash and short-term investmentsTWD 40.3mTWD 64.7mTWD 174.8mTWD 31.8mTWD 31.4mTWD 40.3m—TWD 64.8m
DebtTWD 111.5mTWD 83.4mTWD 141.8mTWD 26.0mTWD 25.3mTWD 19.0m—TWD 110.2m
Shareholders' equityTWD 283.3mTWD 325.8mTWD 379.5mTWD 280.1mTWD 312.8mTWD 327.5m—TWD 286.7m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin60.1%59.6%57.8%53.0%60.9%65.3%
Operating margin-44.9%-48.2%-19.1%-25.4%-27.5%-2.8%
Net margin-47.7%-49.7%-20.4%-27.1%-31.4%-5.8%
Return on equity-35.7%-29.0%-16.9%-15.3%-17.3%-3.6%
Return on assets-20.1%-19.8%-10.7%-10.4%-9.3%-2.0%
Free cash flow yield-7.0%-8.5%-1.4%-0.7%-1.0%6.4%
Revenue growth-5.4%-18.1%25.5%17.2%-13.1%18.7%
Earnings growth-9.3%99.3%-5.4%1.2%369.5%50.8%
Current ratio0.80x2.19x1.52x1.87x0.92x0.81x
Debt to equity0.19x0.26x0.34x0.23x0.61x0.28x
Equity ratio56.3%68.4%63.5%68.3%54.0%55.6%
Interest coverage-25.09x-30.08x-14.39x-16.10x-9.83x-1.06x
R&D as a share of sales46.1%49.9%33.4%30.3%34.9%19.5%
Buybacks as a share of market value0.0%-13.6%0.0%-11.5%0.0%3.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.0%-0.2%—
Operating income18.7%65.8%—
Net income19.6%52.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin59.8%57.6%59.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-15.2-13.2-23.6-23.2-27.9-167.9
Price to sales7.26.64.86.38.89.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.